<p>(A) Western blot analysis of proteins p53, Bcl-2 and Bax in HepG2 cells with DHM treatment for 3, 6, 12, 24 and 48 h. (B) HepG2 cells were treated with DHM (10, 25, 50, 100 and 150 μM) for 12 h. The correlation between p53 and Bcl-2 was shown by western blot assay. (C) Gene expressions of TP53, Bcl-2 and Bax in HepG2 cells treated with DHM for 12 h and 24 h, which were tested by RT-PCR assay. The expression of P53 are 1.8 and 2.8 folds higher than the control, meanwhile the expression of Bcl-2 are 0.8 and 0.4 folds lower than the control respectively. (D) Data shows the correlation between p53 and Bcl-2/Bax in HepG2 cells with DHM treatments of different concentrations for 24 h. The expression of P53 are 1.5 and 2.9 folds higher than the...
<p>(A) The effect of each drug individually and in combination on cell apoptosis in QGY7701, HL7702 ...
<p>CEM cell lysate was prepared following treatment with <b>4a</b> (0, 0.5, 1 and 5 µM for 48 h). DM...
<p>(A) HCT116 (p53<sup>+/+</sup>) and HCT116-p53<sup>-/-</sup> cells were treated with 1 μg/ml of <b...
<p>(<b>A)</b> Effect of DHM on HepG2 cell growth after DHM withdrawal. After administered to cells f...
<p>A. The MMP changes of HepG2 cells treated with DMQ (a) and H-EtOAc fraction (b). B. The productio...
<p><b>A.</b> Left panel: RT-PCR analysis of the indicated Bcl-2 family genes upon bDHC treatment for...
<p>(A) DHM-induced apoptosis in HepG2 cells with different concentrations (a: control, b: 10 μM, c: ...
<div><p>(A) DHC increases p53 lysine 373 and 382 acetylation in a dose-dependent manner in the TK6 c...
<p>(A, B) p53-siRNA was used to knockdown of p53 and rescued the upregulation of p53 in hepatoma cel...
Dihydromyricetin (DHM) is a major active ingredient of flavonoids compounds. It exhibited anticancer...
Apoptosis of HepG2 cells triggered by various agents is characterized in an attempt to delineate t...
<p>Unsynchronized (A) and synchronized (B) HeLa cells were treated with 0, 20, or 30 µM DhL for 24 o...
<p>(A) The p53, p21 and pRb in lysates made from A549 and H292 cells was determined by Western-blot,...
<p>An increase of apoptotic cells was found in CCA cell lines, KKU-M213 and KKU-M214, treated with h...
<p>(A) Synchronized HeLa cells treated with 0–20 µM of DhL were lysed at the indicated times. Immuno...
<p>(A) The effect of each drug individually and in combination on cell apoptosis in QGY7701, HL7702 ...
<p>CEM cell lysate was prepared following treatment with <b>4a</b> (0, 0.5, 1 and 5 µM for 48 h). DM...
<p>(A) HCT116 (p53<sup>+/+</sup>) and HCT116-p53<sup>-/-</sup> cells were treated with 1 μg/ml of <b...
<p>(<b>A)</b> Effect of DHM on HepG2 cell growth after DHM withdrawal. After administered to cells f...
<p>A. The MMP changes of HepG2 cells treated with DMQ (a) and H-EtOAc fraction (b). B. The productio...
<p><b>A.</b> Left panel: RT-PCR analysis of the indicated Bcl-2 family genes upon bDHC treatment for...
<p>(A) DHM-induced apoptosis in HepG2 cells with different concentrations (a: control, b: 10 μM, c: ...
<div><p>(A) DHC increases p53 lysine 373 and 382 acetylation in a dose-dependent manner in the TK6 c...
<p>(A, B) p53-siRNA was used to knockdown of p53 and rescued the upregulation of p53 in hepatoma cel...
Dihydromyricetin (DHM) is a major active ingredient of flavonoids compounds. It exhibited anticancer...
Apoptosis of HepG2 cells triggered by various agents is characterized in an attempt to delineate t...
<p>Unsynchronized (A) and synchronized (B) HeLa cells were treated with 0, 20, or 30 µM DhL for 24 o...
<p>(A) The p53, p21 and pRb in lysates made from A549 and H292 cells was determined by Western-blot,...
<p>An increase of apoptotic cells was found in CCA cell lines, KKU-M213 and KKU-M214, treated with h...
<p>(A) Synchronized HeLa cells treated with 0–20 µM of DhL were lysed at the indicated times. Immuno...
<p>(A) The effect of each drug individually and in combination on cell apoptosis in QGY7701, HL7702 ...
<p>CEM cell lysate was prepared following treatment with <b>4a</b> (0, 0.5, 1 and 5 µM for 48 h). DM...
<p>(A) HCT116 (p53<sup>+/+</sup>) and HCT116-p53<sup>-/-</sup> cells were treated with 1 μg/ml of <b...